IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 21.8 Million USD | -15.35% |
| 2022 | 25.36 Million USD | 11.11% |
| 2021 | 22.83 Million USD | 46.75% |
| 2020 | 15.55 Million USD | -13.27% |
| 2019 | 17.93 Million USD | 2.68% |
| 2018 | 17.47 Million USD | 12.69% |
| 2017 | 15.5 Million USD | -25.61% |
| 2016 | 20.83 Million USD | 4.44% |
| 2015 | 19.95 Million USD | -6.78% |
| 2014 | 21.4 Million USD | 15.16% |
| 2013 | 18.58 Million USD | 13.71% |
| 2012 | 16.34 Million USD | 0.34% |
| 2011 | 16.29 Million USD | -22.07% |
| 2010 | 20.9 Million USD | 3.11% |
| 2009 | 20.27 Million USD | 3.02% |
| 2008 | 19.67 Million USD | -18.96% |
| 2007 | 24.28 Million USD | 29.14% |
| 2006 | 18.8 Million USD | 3.47% |
| 2005 | 18.17 Million USD | 22.08% |
| 2004 | 14.88 Million USD | 5.81% |
| 2003 | 14.07 Million USD | 3.55% |
| 2002 | 13.58 Million USD | 3.96% |
| 2001 | 13.07 Million USD | -33.63% |
| 2000 | 19.69 Million USD | 24.7% |
| 1999 | 15.79 Million USD | 12.79% |
| 1998 | 14 Million USD | 28.44% |
| 1997 | 10.9 Million USD | 41.56% |
| 1996 | 7.7 Million USD | 26.23% |
| 1995 | 6.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.37 Million USD | -8.93% |
| 2024 Q2 | 5.05 Million USD | 15.5% |
| 2023 Q3 | 5.62 Million USD | 4.81% |
| 2023 Q1 | 5.93 Million USD | -10.89% |
| 2023 FY | 21.47 Million USD | -15.35% |
| 2023 Q4 | 4.8 Million USD | -14.55% |
| 2023 Q2 | 5.36 Million USD | -9.68% |
| 2022 FY | 25.36 Million USD | 11.11% |
| 2022 Q4 | 6.66 Million USD | 3.16% |
| 2022 Q3 | 6.46 Million USD | 3.88% |
| 2022 Q1 | 5.97 Million USD | -0.42% |
| 2022 Q2 | 6.21 Million USD | 4.05% |
| 2021 Q4 | 6 Million USD | 3.8% |
| 2021 FY | 22.83 Million USD | 46.75% |
| 2021 Q1 | 4.93 Million USD | -11.52% |
| 2021 Q2 | 6.1 Million USD | 23.67% |
| 2021 Q3 | 5.78 Million USD | -5.34% |
| 2020 Q1 | 3.91 Million USD | -19.26% |
| 2020 Q2 | 2.4 Million USD | -38.56% |
| 2020 Q3 | 3.65 Million USD | 51.87% |
| 2020 Q4 | 5.58 Million USD | 52.76% |
| 2020 FY | 15.55 Million USD | -13.27% |
| 2019 Q2 | 4.54 Million USD | 6.86% |
| 2019 FY | 17.93 Million USD | 2.68% |
| 2019 Q4 | 4.85 Million USD | 13.24% |
| 2019 Q1 | 4.25 Million USD | -9.52% |
| 2019 Q3 | 4.28 Million USD | -5.85% |
| 2018 Q1 | 3.92 Million USD | 80.74% |
| 2018 Q2 | 4.26 Million USD | 8.82% |
| 2018 Q3 | 4.57 Million USD | 7.22% |
| 2018 Q4 | 4.7 Million USD | 2.82% |
| 2018 FY | 17.47 Million USD | 12.69% |
| 2017 Q1 | 4.46 Million USD | -19.74% |
| 2017 Q2 | 4.49 Million USD | 0.67% |
| 2017 Q4 | 2.17 Million USD | -50.38% |
| 2017 Q3 | 4.37 Million USD | -2.71% |
| 2017 FY | 15.5 Million USD | -25.61% |
| 2016 Q1 | 5.29 Million USD | -3.43% |
| 2016 Q2 | 5.73 Million USD | 8.25% |
| 2016 FY | 20.83 Million USD | 4.44% |
| 2016 Q4 | 5.56 Million USD | 31.05% |
| 2016 Q3 | 4.24 Million USD | -25.97% |
| 2015 FY | 19.95 Million USD | -6.78% |
| 2015 Q2 | 4.21 Million USD | -22.05% |
| 2015 Q1 | 5.41 Million USD | -8.32% |
| 2015 Q4 | 5.48 Million USD | 13.3% |
| 2015 Q3 | 4.84 Million USD | 14.8% |
| 2014 FY | 21.4 Million USD | 15.16% |
| 2014 Q1 | 5.05 Million USD | -1.84% |
| 2014 Q2 | 5.3 Million USD | 4.85% |
| 2014 Q3 | 5.14 Million USD | -2.85% |
| 2014 Q4 | 5.9 Million USD | 14.6% |
| 2013 Q4 | 5.15 Million USD | 9.02% |
| 2013 Q3 | 4.72 Million USD | 5.4% |
| 2013 Q2 | 4.48 Million USD | 5.93% |
| 2013 Q1 | 4.23 Million USD | -2.47% |
| 2013 FY | 18.58 Million USD | 13.71% |
| 2012 FY | 16.34 Million USD | 0.34% |
| 2012 Q4 | 4.33 Million USD | 10.92% |
| 2012 Q3 | 3.91 Million USD | -4.86% |
| 2012 Q2 | 4.11 Million USD | 3.14% |
| 2012 Q1 | 3.98 Million USD | 212.87% |
| 2011 Q4 | 1.27 Million USD | -74.01% |
| 2011 Q1 | 5.23 Million USD | -11.11% |
| 2011 Q2 | 4.87 Million USD | -6.89% |
| 2011 FY | 16.29 Million USD | -22.07% |
| 2011 Q3 | 4.9 Million USD | 0.49% |
| 2010 FY | 20.9 Million USD | 3.11% |
| 2010 Q4 | 5.89 Million USD | 12.27% |
| 2010 Q2 | 4.53 Million USD | -13.19% |
| 2010 Q3 | 5.24 Million USD | 15.72% |
| 2010 Q1 | 5.22 Million USD | -0.93% |
| 2009 FY | 20.27 Million USD | 3.02% |
| 2009 Q4 | 5.27 Million USD | 2.97% |
| 2009 Q3 | 5.12 Million USD | 6.07% |
| 2009 Q1 | 5.04 Million USD | 10.87% |
| 2009 Q2 | 4.82 Million USD | -4.34% |
| 2008 Q2 | 5.33 Million USD | 10.95% |
| 2008 Q4 | 4.55 Million USD | -8.76% |
| 2008 Q3 | 4.99 Million USD | -6.4% |
| 2008 FY | 19.67 Million USD | -18.96% |
| 2008 Q1 | 4.8 Million USD | -23.8% |
| 2007 Q1 | 5.2 Million USD | 3.93% |
| 2007 FY | 24.28 Million USD | 29.14% |
| 2007 Q4 | 6.3 Million USD | 1.96% |
| 2007 Q3 | 6.18 Million USD | -6.06% |
| 2007 Q2 | 6.58 Million USD | 26.4% |
| 2006 FY | 18.8 Million USD | 3.47% |
| 2006 Q2 | 4.65 Million USD | 7.23% |
| 2006 Q3 | 4.87 Million USD | 4.57% |
| 2006 Q1 | 4.34 Million USD | -14.35% |
| 2006 Q4 | 5.01 Million USD | 2.87% |
| 2005 Q1 | 3.67 Million USD | -16.33% |
| 2005 Q2 | 4.54 Million USD | 23.57% |
| 2005 Q3 | 4.87 Million USD | 7.35% |
| 2005 Q4 | 5.07 Million USD | 3.98% |
| 2005 FY | 18.17 Million USD | 22.08% |
| 2004 FY | 14.88 Million USD | 5.81% |
| 2004 Q4 | 4.39 Million USD | 26.69% |
| 2004 Q3 | 3.47 Million USD | -8.85% |
| 2004 Q2 | 3.8 Million USD | 18.41% |
| 2004 Q1 | 3.21 Million USD | -22.04% |
| 2003 Q1 | 3.23 Million USD | -25.9% |
| 2003 Q3 | 3.58 Million USD | 15.03% |
| 2003 Q4 | 4.12 Million USD | 14.91% |
| 2003 Q2 | 3.12 Million USD | -3.64% |
| 2003 FY | 14.07 Million USD | 3.55% |
| 2002 Q2 | 3.12 Million USD | 1.17% |
| 2002 Q1 | 3.08 Million USD | -12.16% |
| 2002 FY | 13.58 Million USD | 3.96% |
| 2002 Q4 | 4.37 Million USD | 45.09% |
| 2002 Q3 | 3.01 Million USD | -3.49% |
| 2001 Q4 | 3.51 Million USD | 0.4% |
| 2001 Q3 | 3.49 Million USD | -5.38% |
| 2001 Q2 | 3.69 Million USD | 56.45% |
| 2001 Q1 | 2.36 Million USD | -46.76% |
| 2001 FY | 13.07 Million USD | -33.63% |
| 2000 FY | 19.69 Million USD | 24.7% |
| 2000 Q4 | 4.43 Million USD | -9.08% |
| 2000 Q3 | 4.88 Million USD | -7.98% |
| 2000 Q2 | 5.3 Million USD | 4.59% |
| 2000 Q1 | 5.07 Million USD | 1.6% |
| 1999 Q1 | 3.3 Million USD | -17.5% |
| 1999 FY | 15.79 Million USD | 12.79% |
| 1999 Q4 | 4.99 Million USD | 34.89% |
| 1999 Q3 | 3.7 Million USD | -2.63% |
| 1999 Q2 | 3.8 Million USD | 15.15% |
| 1998 FY | 14 Million USD | 28.44% |
| 1998 Q4 | 4 Million USD | 48.15% |
| 1998 Q3 | 2.7 Million USD | -25.0% |
| 1998 Q2 | 3.6 Million USD | 0.0% |
| 1998 Q1 | 3.6 Million USD | -2.7% |
| 1997 Q4 | 3.7 Million USD | 37.04% |
| 1997 FY | 10.9 Million USD | 41.56% |
| 1997 Q2 | 2.7 Million USD | 35.0% |
| 1997 Q1 | 2 Million USD | -31.03% |
| 1997 Q3 | 2.7 Million USD | 0.0% |
| 1996 FY | 7.7 Million USD | 26.23% |
| 1996 Q1 | 2.4 Million USD | 4.35% |
| 1996 Q2 | 1.7 Million USD | -29.17% |
| 1996 Q3 | 1.6 Million USD | -5.88% |
| 1996 Q4 | 2.9 Million USD | 81.25% |
| 1995 FY | 6.1 Million USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -4.55% |
| 1995 Q4 | 2.3 Million USD | 9.52% |
| 1995 Q1 | 2.1 Million USD | 0.0% |
| 1995 Q2 | 2.2 Million USD | 4.76% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -755.176% |
| BrainsWay Ltd. | 23.09 Million USD | 5.561% |
| Cerus Corporation | 86.4 Million USD | 74.76% |
| Envoy Medical, Inc. | -473 Thousand USD | 4710.359% |
| electroCore, Inc. | 13.22 Million USD | -64.88% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -35649.18% |
| IceCure Medical Ltd | 1.3 Million USD | -1577.462% |
| Inogen, Inc. | 126.69 Million USD | 82.788% |
| OrthoPediatrics Corp. | 111.25 Million USD | 80.399% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 460.446% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 46168.531% |
| MaxCyte, Inc. | 36.54 Million USD | 40.33% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -4676.821% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -25537.197% |
| Orthofix Medical Inc. | 486.27 Million USD | 95.515% |
| PAVmed Inc | -3.96 Million USD | 649.572% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 497.575% |
| RxSight, Inc. | 53.76 Million USD | 59.44% |
| Sight Sciences, Inc. | 69.17 Million USD | 68.476% |
| SI-BONE, Inc. | 109.42 Million USD | 80.07% |
| TELA Bio, Inc. | 40.11 Million USD | 45.635% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 85.647% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -163.656% |
| Acutus Medical, Inc. | -3.13 Million USD | 795.155% |
| Talis Biomedical Corporation | 371 Thousand USD | -5777.898% |
| Spectral AI, Inc. | 7.88 Million USD | -176.739% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 430.81% |
| CVRx, Inc. | 33.03 Million USD | 33.996% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -2848.781% |
| Bioventus Inc. | 328.19 Million USD | 93.355% |
| Venus Concept Inc. | 52.16 Million USD | 58.198% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -37.099% |
| LivaNova PLC | 771.25 Million USD | 97.173% |
| 908 Devices Inc. | 25.32 Million USD | 13.881% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 92.97% |
| Nemaura Medical Inc. | -1.47 Million USD | 1577.047% |
| NeuroPace, Inc. | 48.12 Million USD | 54.684% |
| LENSAR, Inc. | 21.1 Million USD | -3.316% |
| Apyx Medical Corporation | 14.12 Million USD | -54.419% |
| Cutera, Inc. | 41.49 Million USD | 47.445% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -18.125% |
| BioSig Technologies, Inc. | 18 Thousand USD | -121050.0% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 78.846% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -60.181% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 97.545% |
| Axonics, Inc. | 274.55 Million USD | 92.057% |
| Outset Medical, Inc. | 29 Million USD | 24.803% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 69.307% |
| IRadimed Corporation | 50.15 Million USD | 56.524% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -7498.258% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1907.756% |
| Telesis Bio, Inc. | 16.95 Million USD | -28.655% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 80.665% |
| Varex Imaging Corporation | 256.9 Million USD | 91.511% |
| Quipt Home Medical Corp. | 163.84 Million USD | 86.69% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5471.182% |
| Pulmonx Corporation | 50.75 Million USD | 57.032% |
| Dynatronics Corporation | 7.63 Million USD | -185.62% |
| Modular Medical, Inc. | -768 Thousand USD | 2939.453% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -293.061% |
| Semler Scientific, Inc. | 61.2 Million USD | 64.368% |
| InMode Ltd. | 411.34 Million USD | 94.699% |
| Bruker Corporation | 1.51 Billion USD | 98.562% |
| Cytosorbents Corporation | 22.39 Million USD | 2.613% |
| DexCom, Inc. | 2.28 Billion USD | 99.047% |
| Align Technology, Inc. | 2.71 Billion USD | 99.198% |
| Viveve Medical, Inc. | 620 Thousand USD | -3417.258% |
| ZimVie Inc. | 290.38 Million USD | 92.49% |
| Movano Inc. | -158 Thousand USD | 13901.899% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 80.071% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -25537.197% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 94.069% |
| Profound Medical Corp. | 4.51 Million USD | -383.095% |
| Insulet Corporation | 1.15 Billion USD | 98.12% |
| enVVeno Medical Corporation | -546 Thousand USD | 4093.956% |
| Surmodics, Inc. | 93.05 Million USD | 76.565% |
| iCAD, Inc. | 14.53 Million USD | -50.021% |
| Nuwellis, Inc. | 4.98 Million USD | -337.628% |
| Biotricity, Inc. | 8.35 Million USD | -160.965% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 93.428% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 6173.409% |
| InspireMD, Inc. | 1.8 Million USD | -1106.807% |
| PAVmed Inc. | -3.96 Million USD | 649.572% |
| BIOLASE, Inc. | 16.72 Million USD | -30.393% |
| Beyond Air, Inc. | -1.3 Million USD | 1768.477% |
| FONAR Corporation | 45.14 Million USD | 51.69% |
| AxoGen, Inc. | 127.87 Million USD | 82.946% |
| Vivani Medical, Inc. | -357 Thousand USD | 6208.403% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 88.825% |
| Inari Medical, Inc. | 434.56 Million USD | 94.982% |
| UFP Technologies, Inc. | 112.22 Million USD | 80.569% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -174091.229% |
| Tenon Medical, Inc. | 1.24 Million USD | -1657.212% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 27022.222% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -730.082% |
| AdaptHealth Corp. | 479.56 Million USD | 95.453% |
| Sintx Technologies, Inc. | 1.84 Million USD | -1083.234% |
| NanoVibronix, Inc. | 1.53 Million USD | -1318.803% |
| Quanterix Corporation | 70.64 Million USD | 69.132% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5471.182% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -55.1% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 58.683% |
| TransMedics Group, Inc. | 154.09 Million USD | 85.848% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -389.715% |
| NeuroMetrix, Inc. | 3.94 Million USD | -452.438% |
| Hyperfine, Inc. | 4.75 Million USD | -358.419% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 79.615% |
| Biomerica, Inc. | 611 Thousand USD | -3469.067% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 47.689% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 2892.35% |
| Silk Road Medical, Inc | 127.08 Million USD | 82.841% |